Mucosal cytokine imbalance in irritable bowel syndrome
- 1 January 2008
- journal article
- research article
- Published by Taylor & Francis Ltd in Scandinavian Journal of Gastroenterology
- Vol. 43 (12), 1467-1476
- https://doi.org/10.1080/00365520802276127
Abstract
Objective. To systematically examine mucosal biopsies for differences in cytokine gene expression and protein secretion. Material and methods. The study included 59 females with irritable bowel syndrome (IBS) and 39, otherwise healthy, female volunteers presenting for colonoscopy. Colonic biopsies from subsets were studied by microarray analysis (IBS, n=9; controls, n=8), quantitative reverse transcription-polymerase chain reaction (qRT-PCR) (IBS, n=22; controls, n=21), and ex vivo biopsy culture (IBS, n=28, controls, n=10). Biopsies from patients with active colitis were used as inflammatory disease controls. Results. While gene array analysis revealed extensive overlapping between controls and IBS patients, reduced expression of genes linked to chemokine function was evident among the IBS patients alone. Differential expression was confirmed by qRT-PCR or ex vivo biopsy culture for 5 out of 6 selected genes. Reduced secretion of chemokines (IL-8, CXCL-9 and MCP-1) but not pro-inflammatory cytokines (TNF-α, IL-6 and IL-1β) was established on the basis of the ex vivo biopsy cultures. These findings were in marked contrast to the IBD patients who demonstrated increased production of both chemokines and pro-inflammatory cytokines. Conclusions. Despite the expected heterogeneity of the disorder, differences in mucosal chemokine signalling were evident in this cross-sectional study of IBS patients at the level of both gene expression and protein secretion, with IBS patients demonstrating a consistent deficit in the expression and secretion of chemokines known to play a critical role in mucosal defence.Keywords
This publication has 36 references indexed in Scilit:
- Role for protease activity in visceral pain in irritable bowel syndromeJCI Insight, 2007
- Diarrhoea-predominant IBS patients show mast cell activation and hyperplasia in the jejunumGut, 2007
- CD4+CD25+regulatory T cells in irritable bowel syndrome patientsNeurogastroenterology & Motility, 2006
- Suppressive effect of Clostridium perfringens-produced heat-stable substance(s) on proliferation of human colon adenocarcinoma HT29 cells in cultureCancer Letters, 2006
- Functional Bowel DisordersGastroenterology, 2006
- Hypothalamic-Pituitary-Gut Axis Dysregulation in Irritable Bowel Syndrome: Plasma Cytokines as a Potential Biomarker?Gastroenterology, 2006
- Dual Function of Interleukin-1β for the Regulation of Interleukin-6-induced Suppressor of Cytokine Signaling 3 ExpressionPublished by Elsevier BV ,2004
- Many chemokines including CCL20/MIP-3α display antimicrobial activityJournal of Leukocyte Biology, 2003
- Postinfectious irritable bowel syndromeGastroenterology, 2003
- Epithelial cells as sensors for microbial infection.JCI Insight, 1997